1917

It is founded
Istituto Gentili

1917-97

Marketing
of products under the
Istituto Gentili brand

2009

The Mediolanum
pharmaceutical group
takes over the Istituto Gentili
from Merck Sharp & Dohme
Italia group

2017

AcquisitionTherabel

by the

Mediolanum Pharmaceutical

group

2017

With the deal with

Novartis Farma S.p.A

the new reality of Istituto Gentili
is born,
entirely focused on
oncology

2018

The acquisition of
Teva's Italia Srl OncoCare products

further strengthens
the Portfolio of
Istituto Gentili's products